162358-05-6 Usage
Description
2-(4-Octylphenyl)ethanol, with the CAS number 162358-05-6, is an organic compound characterized by its oily texture. It is primarily utilized in the field of organic synthesis, where its unique chemical properties contribute to the creation of various complex molecules and structures.
Uses
Used in Organic Synthesis:
2-(4-Octylphenyl)ethanol is used as a synthetic building block for the development of more complex organic compounds. Its oily nature and compatibility with a range of chemical reactions make it a valuable component in the synthesis of various organic molecules.
Used in Chemical Industry:
In the chemical industry, 2-(4-Octylphenyl)ethanol is employed as an intermediate in the production of specialty chemicals, pharmaceuticals, and other advanced materials. Its unique structure and properties allow for the creation of novel compounds with specific applications and functions.
Used in Pharmaceutical Industry:
2-(4-Octylphenyl)ethanol may also find application in the pharmaceutical industry, where it can be used as a starting material for the synthesis of new drugs or as a component in the formulation of existing medications. Its versatility in organic synthesis makes it a promising candidate for the development of innovative pharmaceutical products.
Check Digit Verification of cas no
The CAS Registry Mumber 162358-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,2,3,5 and 8 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 162358-05:
(8*1)+(7*6)+(6*2)+(5*3)+(4*5)+(3*8)+(2*0)+(1*5)=126
126 % 10 = 6
So 162358-05-6 is a valid CAS Registry Number.
InChI:InChI=1S/C16H26O/c1-2-3-4-5-6-7-8-15-9-11-16(12-10-15)13-14-17/h9-12,17H,2-8,13-14H2,1H3
162358-05-6Relevant articles and documents
Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia
Toop, Hamish D.,Dun, Matthew D.,Ross, Bryony K.,Flanagan, Hayley M.,Verrills, Nicole M.,Morris, Jonathan C.
, p. 4605 - 4616 (2016)
AAL(S), the chiral deoxy analog of the FDA approved drug FTY720, has been shown to inhibit proliferation and apoptosis in several cancer cell lines. It has been suggested that it does this by activating protein phosphatase 2A (PP2A). Here we report the synthesis of new cytotoxic analogs of AAL(S) and the evaluation of their cytotoxicity in two myeloid cell lines, one of which is sensitive to PP2A activation. We show that these analogs activate PP2A in these cells supporting the suggested mechanism for their cytotoxic properties. Our findings identify key structural motifs required for anti-cancer effects.
PROCESS FOR PREPARATION OF FINGOLIMOD
-
, (2015/02/18)
The present invention provides a process for preparation of fingolimod, a compound of Formula I or a pharmaceutically acceptable salt thereof, free of regioisomeric impurity compound of Formula IA
SELECTIVE INHIBITORS AND ALLOSTERIC ACTIVATORS OF SPHINGOSINE KINASE
-
, (2014/08/19)
Sphingosine 1-phosphate (S1P) is involved in hyper-proliferative diseases, such as cancer and vascular remodeling in pulmonary arterial hypertension. Inhibitors of sphingosine kinase 1 and 2 (SK1 and SK2), which catalyze the synthesis of S1P, may be useful anti- proliferative agents. We have synthesized a series of sphingosine-based inhibitors of SK and SK2. Also provided in this invention are compounds that activate SK1 which can be used in diseases such as fibrosis, where intracellular S1P is anti-fibrotic.